These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 6295008)

  • 81. Lymphocyte transformation induced by autologous cells. VIII. Impaired autologous mixed lymphocyte reactivity in patients with acute infectious mononucleosis.
    Moody CE; Casazza BA; Christenson WN; Weksler ME
    J Exp Med; 1979 Dec; 150(6):1448-55. PubMed ID: 229189
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Activation of lymphocytes from Epstein-Barr virus-seronegative donors by autologous Epstein-Barr virus-transformed cells.
    Chang RS; Chang YY
    J Infect Dis; 1980 Aug; 142(2):156-62. PubMed ID: 6251138
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Epstein-Barr virus-transformed human B lymphocytes produce natural antibodies to histones.
    Garzelli C; Incaprera M; Bazzichi A; Manunta M; Rognini F; Falcone G
    Immunol Lett; 1994 Mar; 39(3):277-82. PubMed ID: 7518420
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Simultaneous presence of EBNA-positive and colony-forming cells in peripheral blood of patients with infectious mononucleosis.
    Katsuki T; Hinuma Y; Saito T; Yamamoto J; Hirashima Y; Sudoh H; Deguchi M; Motokawa M
    Int J Cancer; 1979 Jun; 23(6):746-50. PubMed ID: 223990
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients.
    Rickinson AB; Moss DJ; Pope JH; Ahlberg N
    Int J Cancer; 1980 Jan; 25(1):59-65. PubMed ID: 6249763
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Polyclonal proliferation of activated suppressor/cytotoxic T cells with transient depression of natural killer cell function in acute infectious mononucleosis.
    Williams ML; Loughran TP; Kidd PG; Starkebaum GA
    Clin Exp Immunol; 1989 Jul; 77(1):71-6. PubMed ID: 2527653
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Cytotoxicity of human T-lymphocytes sensitized by Epstein-Barr virus. Role of HLA antigens at the surface of target cells infected by the virus].
    Tursz T; Fridman WH; Tsapis A; Senik A; Fellous M
    C R Acad Hebd Seances Acad Sci D; 1977 May; 284(20):2063-6. PubMed ID: 196780
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Transient immune deficiency in patients with acute Epstein-Barr virus infection.
    Junker AK; Ochs HD; Clark EA; Puterman ML; Wedgwood RJ
    Clin Immunol Immunopathol; 1986 Sep; 40(3):436-46. PubMed ID: 3015461
    [TBL] [Abstract][Full Text] [Related]  

  • 89. EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients.
    Klein G; Svedmyr E; Jondal M; Persson PO
    Int J Cancer; 1976 Jan; 17(1):21-6. PubMed ID: 55396
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Infectious mononucleosis: a polyclonal B cell transformation in vivo.
    Brown N; Smith D; Miller G; Niederman J; Liu C; Robinson J
    J Infect Dis; 1984 Oct; 150(4):517-22. PubMed ID: 6092482
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Transformation induced by Epstein-Barr virus and the role of the nuclear antigen.
    Klein G; Luka J; Zeuthen J
    Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():253-61. PubMed ID: 6253139
    [No Abstract]   [Full Text] [Related]  

  • 92. Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities.
    Yao QY; Czarnecka H; Rickinson AB
    Int J Cancer; 1991 May; 48(2):253-7. PubMed ID: 1850387
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Neuramide inhibits Epstein-Barr virus-induced transformation activity and proliferation of transformed B lymphocytes.
    Venanzoni MC; Angeloni A; Di Muzio M; Faggioni A; Frati L
    Antiviral Res; 1997 Feb; 33(3):177-85. PubMed ID: 9037374
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.
    Bangham CR; McMichael AJ
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9183-7. PubMed ID: 3097646
    [TBL] [Abstract][Full Text] [Related]  

  • 95. B-cell lymphoproliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein-Barr virus.
    Brown NA; Liu CR; Wang YF; Garcia CR
    J Virol; 1988 Mar; 62(3):962-9. PubMed ID: 2828691
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus.
    Chisari FV; Curtiss LK; Jensen FC
    J Clin Invest; 1981 Aug; 68(2):329-36. PubMed ID: 6267100
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Isoprinosine abolishes the blocking factor-mediated inhibition of lymphocyte responses to Epstein-Barr virus antigens and phytohemagglutinin.
    Sundar SK; Menezes J
    Int J Immunopharmacol; 1986; 8(1):101-6. PubMed ID: 2420730
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes.
    Tomita Y; Avila-Cariño J; Yamamoto K; Mellstedt H; Klein E
    Immunol Lett; 1998 Feb; 60(2-3):73-9. PubMed ID: 9580478
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A.
    von Knebel Doeberitz M; Bornkamm GW; zur Hausen H
    Med Microbiol Immunol; 1983; 172(2):87-99. PubMed ID: 6310356
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Epstein-Barr virus infection and immunoregulation in man.
    Tosato G; Blaese RM
    Adv Immunol; 1985; 37():99-149. PubMed ID: 2988307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.